View in EDS

O4 - Patient outcomes based on prognostic risk groups in METEOR, a randomized phase 3 study of cabozantinib (cabo) versus everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).

Saved in:
Bibliographic Details
Title: O4 - Patient outcomes based on prognostic risk groups in METEOR, a randomized phase 3 study of cabozantinib (cabo) versus everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).
Authors: Powles, T., Motzer, R.J., Escudier, B., Heng, D.Y.C., Scheffold, C., Clary, D.O., Choueiri, T.K.
Source: European Urology Supplements. Dec2016, Vol. 15 Issue 13, pe1546-e1547. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 119813113
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: O4 - Patient outcomes based on prognostic risk groups in METEOR, a randomized phase 3 study of cabozantinib (cabo) versus everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Powles%2C+T%2E%22">Powles, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Motzer%2C+R%2EJ%2E%22">Motzer, R.J.</searchLink><br /><searchLink fieldCode="AR" term="%22Escudier%2C+B%2E%22">Escudier, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Heng%2C+D%2EY%2EC%2E%22">Heng, D.Y.C.</searchLink><br /><searchLink fieldCode="AR" term="%22Scheffold%2C+C%2E%22">Scheffold, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Clary%2C+D%2EO%2E%22">Clary, D.O.</searchLink><br /><searchLink fieldCode="AR" term="%22Choueiri%2C+T%2EK%2E%22">Choueiri, T.K.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Urology+Supplements%22">European Urology Supplements</searchLink>. Dec2016, Vol. 15 Issue 13, pe1546-e1547. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=119813113
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1569-9056(16)30377-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: e1546
    Titles:
      – TitleFull: O4 - Patient outcomes based on prognostic risk groups in METEOR, a randomized phase 3 study of cabozantinib (cabo) versus everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Powles, T.
      – PersonEntity:
          Name:
            NameFull: Motzer, R.J.
      – PersonEntity:
          Name:
            NameFull: Escudier, B.
      – PersonEntity:
          Name:
            NameFull: Heng, D.Y.C.
      – PersonEntity:
          Name:
            NameFull: Scheffold, C.
      – PersonEntity:
          Name:
            NameFull: Clary, D.O.
      – PersonEntity:
          Name:
            NameFull: Choueiri, T.K.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 12
              Text: Dec2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 15699056
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: European Urology Supplements
              Type: main
ResultId 1